Lv5
1300 积分 2022-10-10 加入
177Lu-Labeled Antibody–Drug Conjugate: A Dual-Mechanistic Treatment Modality in Solid Tumors
2个月前
已完结
177Lu-FAPI-2286 Therapy in a Patient With Radio-iodine Refractory Papillary Thyroid Carcinoma: A Favorable Clinical and Biochemical Response
2个月前
已完结
177Lu-FAPI Therapy in a Patient With End-Stage Metastatic Pancreatic Adenocarcinoma
2个月前
已完结
225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience
2个月前
已完结
Sequential use of targeted radioligand therapies in metastatic castration-resistant prostate cancer: A case report and systematic review
2个月前
已完结
New Targets for Imaging in Nuclear Medicine
2个月前
已完结
BNCT pancreatic cancer treatment strategy with glucose-conjugated boron drug
4个月前
已完结
Leveraging the immune system to treat advanced thyroid cancers
8个月前
已完结
Thyroid autoimmune disorders and cancer
8个月前
已完结
Prognostic Value of Hematological Inflammatory Indices (PLR, NLR, SII) in Medium and High‐Risk Papillary Thyroid Carcinoma: A Multicenter Cohort Study
8个月前
已完结
皖公网安备34019202002308
